Back to CELG-RI
Sumitomo Mitsui Trust Group, Inc. → CELG-RI
Sumitomo Mitsui Trust Group, Inc. CELG-RI Position History
Bristol-Myers Squibb Company Ce • Healthcare
Quarters held
4
Latest value
$316.6M
Q3 2026
Peak value
$316.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $280.8M |
| Q1 2026 | $275.5M |
| Q2 2026 | $293.4M |
| Q3 2026 | $316.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $316.6M | 5.07M | — | — |
| Q2 2026 | $293.4M | 5.09M | — | — |
| Q1 2026 | $275.5M | 4.54M | — | — |
| Q4 2025 | $280.8M | 5.21M | — | — |
Other funds holding CELG-RI
$11.1B
$9.6B
$8.5B
$7.9B
$5.9B
$5.9B
$5.8B